index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

55 Publications avec texte intégral

Open Access

46 %

Mots clés

Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Ectopic germinal centers MYB Centres germinatifs ectopiques Interleukine-23 Immune response Chemokines Immunity Acetylcholine receptors Lamin A/C nuclei Genetic associations Autoimmune disease Interferon type I Long-term follow-up Interféron de type I Neuromuscular junction Adaptive immunity COVID-19 Chronic inflammation COX2 Cardiomyopathy Disease susceptibility Cytokines MiR-125 Exercise Conduction disease Fragile X syndromes Experimental autoimmune myasthenia gravis EAMG AChR antibodies Immune regulation Inflammation BAFF Cellules th17 Thymic epithelial cells Endogenous nucleic acids MG patients Clinical cell transplantation Interferon LMNA Transcriptome CXCL13-CXCR5 CD31 Early-onset myasthenia gravis Mass cytometry CyTOF Macrophages Acetylcholine receptor antibodies Auto-immunité Inflammatory cytokines Myoblasts Thymoma Experimental mouse models Chronicity Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Interferonopathy Glucocorticoids Heart failure Human myoblasts Experimental autoimmune myasthenia gravis Thymus Gd T cells Germinal centers Interferon de type I Il-23 Quality of life Interferon IFN Myasthenia gravis DICER Genetics PBMC Immunology and Microbiology Section MiR-7 Myasthenia Gravis MG Gender Ferrites Experimental models Interferon type-I CCL21 Innate immunity Max FMR1 Interleukin 23 Autoimmunity Animal models Myasthénie grave M3243AG Interferon-β Acetylcholine receptor Autoimmune diseases Complete Freund's adjuvant Anticorps monoclonal CTCF Acides nucléiques endogènes Antimir-150 Immunotherapy Germinal center Chemokine B cells Th17 cells Etiology Maladie auto-immune